Digital Repository

Clozapine induced severe weight loss in resistant schizophrenia managed with risperidone add-on therapy

Show simple item record

dc.contributor.author Chandradasa, M.
dc.contributor.author Kuruppuarachchi, C.S.
dc.contributor.author Rathnayake, L.C.
dc.contributor.author Kuruppuarachchi, K.A.L.A.
dc.date.accessioned 2021-02-18T09:39:45Z
dc.date.available 2021-02-18T09:39:45Z
dc.date.issued 2020
dc.identifier.citation Sri Lanka Journal of Psychiatry.2020; 11(2): 38–39. en_US
dc.identifier.issn 2579-2008
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/22007
dc.description Not indexed in MEDLINE en_US
dc.description.abstract ABSTRACT: Clozapine is prescribed for resistant schizophrenia. It is usually associated with weight gain. There have been only a few reports of weight loss associated with clozapine treatment and we report two patients from Sri Lanka. The first patient lost 27% of bodyweight on clozapine while the second lost 17%. Both were clinically stable on clozapine, with marked reduction of psychotic symptoms. Adding risperidone helped to regain the lost weight in the described patients. KEYWORDS: Clozapine, Weight, Schizophrenia, Sri Lanka en_US
dc.language.iso en_US en_US
dc.publisher Sri Lanka College of Psychiatrists en_US
dc.subject weight loss en_US
dc.title Clozapine induced severe weight loss in resistant schizophrenia managed with risperidone add-on therapy en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account